Key facts
- Notable investors include Pudong Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Shanghai Chuangshengji Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Shanghai Chuangshengji Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Shanghai Chuangshengji Technology
Provider of biotechnology research and development services catering to the life sciences sector. The company offers gene editing, cell engineering, molecular biology research, laboratory testing, and technical consulting, thereby enabling advancements in biomedical research, improved experimental accuracy, and support for therapeutic development.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Shanghai Chuangshengji Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Shanghai Chuangshengji Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Shanghai Chuangshengji Technology in its N-PORT filings yet. We sweep new filings monthly.